# Sanjiv J. Shah

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sanjiv-j-shah/

## Facts

| Field | Value |
| --- | --- |
| Citations | 66,315 |
| Field | Cardiovascular Function and Risk Factors |
| h-index | 120 |
| i10-index | 587 |
| Last Known Institution | Northwestern University |
| OpenAlex ID | https://openalex.org/A5005215114 |
| ORCID iD | 0000-0002-5655-8201 |
| Works | 1,179 |

## Researcher papers

Showing 12 of 26.

- [Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy](https://scholariq.org/papers/tafamidis-treatment-for-patients-with-transthyretin-amyloid-cardiomyopathy/)
- [Spironolactone for Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/spironolactone-for-heart-failure-with-preserved-ejection-fraction/)
- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)
- [Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction](https://scholariq.org/papers/angiotensin-neprilysin-inhibition-in-heart-failure-with-preserved-ejection/)
- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/phenomapping-for-novel-classification-of-heart-failure-with-preserved-ejection/)
- [Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial](https://scholariq.org/papers/regional-variation-in-patients-and-outcomes-in-the-treatment-of-preserved/)
- [Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/phenotype-specific-treatment-of-heart-failure-with-preserved-ejection-fraction/)
- [Fully Automated Echocardiogram Interpretation in Clinical Practice](https://scholariq.org/papers/fully-automated-echocardiogram-interpretation-in-clinical-practice/)
- [SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials](https://scholariq.org/papers/sglt2-inhibitors-in-patients-with-heart-failure-a-comprehensive-meta-analysis-of/)
- [Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/finerenone-in-heart-failure-with-mildly-reduced-or-preserved-ejection-fraction/)
- [Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes](https://scholariq.org/papers/semaglutide-in-patients-with-obesity-related-heart-failure-and-type-2-diabetes/)

## Researcher topics

- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)

## Researcher university

- [Northwestern University](https://scholariq.org/institutions/northwestern-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.